Literature DB >> 13637199

Myocardial oxygen consumption and coronary blood flow in hypothermia.

A GEROLA, H FEINBERG, L N KATZ.   

Abstract

Entities:  

Keywords:  CORONARY VESSELS/physiology; HYPOTHERMIA/effects; MYOCARDIUM/metabolism

Mesh：

Year:  1959        PMID： 13637199     DOI： 10.1152/ajplegacy.1959.196.4.719

Source DB:  PubMed          Journal:  Am J Physiol        ISSN： 0002-9513


× No keyword cloud information.
  7 in total

Review 1.  [Involvement of basal oxygen consumption, activation of myocardium as well as of hemodynamic parameters in total oxygen consumption of the heart].

Authors:  R Krebs
Journal:  Klin Wochenschr       Date:  1970-07-01

2.  Effect of moderate hypothermia in the treatment of canine hemorrhagic shock.

Authors:  D M Meyer; J W Horton
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

3.  Hypothermia in cardiogenic shock reduces systemic t-PA release.

Authors:  Jesper van der Pals; Michael I Götberg; Matthias Götberg; Lillemor Mattsson Hultén; Mia Magnusson; Sverker Jern; David Erlinge
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

4.  Mild hypothermia markedly reduces ischemia related coronary t-PA release.

Authors:  Jesper van der Pals; Matthias Götberg; Göran K Olivecrona; Helen Brogren; Sverker Jern; David Erlinge
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

5.  The effects of hypothermia on myocardial oxygen consumption and transmural coronary blood flow in the potassium-arrested heart.

Authors:  W R Chitwood; J D Sink; R C Hill; A S Wechsler; D C Sabiston
Journal:  Ann Surg       Date:  1979-07       Impact factor: 12.969

6.  METMYOGLOBIN OXIDATION DURING ELECTRON TRANSPORT REACTIONS IN MITOCHONDRIA.

Authors:  A E KAPLAN-BRESLER
Journal:  J Gen Physiol       Date:  1965-03       Impact factor: 4.086

7.  Mild hypothermia reduces cardiac post-ischemic reactive hyperemia.

Authors:  Goran K Olivecrona; Matthias Götberg; Jan Harnek; Jesper Van der Pals; David Erlinge
Journal:  BMC Cardiovasc Disord       Date:  2007-02-26       Impact factor: 2.298
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.